Posted by Shawn. T. on July 4, 2005, at 13:24:04
In reply to Re: Saredutant looks like a winner, posted by ravenstorm on July 4, 2005, at 10:56:38
According to Schoor et al. (1998) in a study involving 12 mild asthmatics, "Saredutant was biologically and clinically well tolerated and no serious events were noted. Two non serious events were noted: patients number 7 and 11 both experienced mild frontal headache on the active treatment day; in both cases it subsided spontaneously until complete recovery." That's not much information, but I strongly doubt that saredutant will have more side effects than SSRIs. I don't know enough about SR 58611 to speculate about it.
Shawn
http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=9701408
poster:Shawn. T.
thread:523047
URL: http://www.dr-bob.org/babble/20050702/msgs/523313.html